Arturo Garza Cavazos, MD

Assistant Director of Minimally Invasive Gynecologic Surgery
Obstetrics and Gynecology
Accepting new patients
Call for an appointment

    About me

    • Board Certification: Obstetrics and Gynecology
    • Specialties:
      • Obstetrical Care of the Low and High Risk Patient
      •  Minimally Invasive Gynecologic Surgery
      •  Surgical Education
      •  Office Gynecology
    • Clinic Locations:



    Additional languages spoken


    Education & training

    Associate Professor
    Board Certifications
    Obstetrics & Gynecology
    Medical School
    Boston University School of Medicine, Boston, MA
    University of Miami/Jackson Memorial Medical Center, Miami, FL
    SIU School of Medicine, Springfield, IL - Minimally Invasive Gynecologic Surgery

    Clinical locations


    SIU OB-GYN at HSHS St. John's Health Center

    1100 Lincolnshire Blvd. Springfield, IL 62703 Suite 200
    Mon - Fri: 8:00 am-4:30 pm

    Hospital privileges

    • HSHS St. John's Hospital, Springfield, IL
    • Memorial Health, Springfield IL


    Research Interests
    Pelvic pain and minimally invasive gynecologic surgery.

    Clinical trials

    Obstetrics and Gynecology

    Endometriosis and the Microbiome

    Active recruiting

    PURPOSE: Endometriosis is an inflammatory disorder in which the tissue that lines the inside of the uterus (the endometrium) spreads to the pelvic and peritoneal cavities outside of the uterus. This is a biological sample collection study examining how bacteria located within the vagina, the urogenital tract and the gastrointestinal tract may affect the development of endometriosis. Investigators are also exploring how an individual’s microbiome affects their estrogen metabolism and inflammation.

    Obstetrics and Gynecology

    Biomarkers for Endometrial and Ovarian Cancer

    Active recruiting

    PURPOSE: This is a biological sample collection study aimed at developing an early diagnostic tool for endometrial and ovarian cancer. The investigators are studying the relationship between estrogen driven gynecological cancers, inflammation and the microbiome. Patients who have been diagnosed with endometrial cancer or undergo presurgical evaluation for suspicion of ovarian cancer who are scheduled for a hysterectomy, bilateral oophorectomy and/or salpingectomy are eligible. Control patients undergoing gynecological surgery for benign indications are also being recruited.